Form 8-K - Current report:
SEC Accession No. 0001558370-22-018730
Filing Date
2022-12-15
Accepted
2022-12-15 17:10:48
Documents
14
Period of Report
2022-12-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vstm-20221213x8k.htm   iXBRL 8-K 39835
2 EX-99.1 vstm-20221213xex99d1.htm EX-99.1 21640
3 GRAPHIC vstm-20221213xex99d1001.jpg GRAPHIC 5017
  Complete submission text file 0001558370-22-018730.txt   195569

Data Files

Seq Description Document Type Size
4 EX-101.SCH vstm-20221213.xsd EX-101.SCH 3237
5 EX-101.LAB vstm-20221213_lab.xml EX-101.LAB 16024
6 EX-101.PRE vstm-20221213_pre.xml EX-101.PRE 10798
8 EXTRACTED XBRL INSTANCE DOCUMENT vstm-20221213x8k_htm.xml XML 4896
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35403 | Film No.: 221465608
SIC: 2834 Pharmaceutical Preparations